RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for BPC157 Seven Hills Medical Centr Should You Try MOTS c and BPC 157 Longevity Peptides? Separating Truth from Hype with Human Data Studies FDA Compliance for Peptide Therapy and BPC 157 Holt Law